Your shopping cart is currently empty

Isoliquiritigenin (ISL) is a flavonoid natural product that inhibits influenza virus replication (EC50=24.7 μM) and aldose reductase activity (IC50=320 nM). Isoliquiritigenin has antitumor activity.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | $33 | In Stock | In Stock | |
| 25 mg | $50 | In Stock | In Stock | |
| 50 mg | $62 | In Stock | In Stock | |
| 100 mg | $85 | In Stock | In Stock | |
| 500 mg | $198 | In Stock | - | |
| 1 mL x 10 mM (in DMSO) | $46 | In Stock | In Stock |
| Description | Isoliquiritigenin (ISL) is a flavonoid natural product that inhibits influenza virus replication (EC50=24.7 μM) and aldose reductase activity (IC50=320 nM). Isoliquiritigenin has antitumor activity. |
| Targets&IC50 | Aldose reductase:320 nM, LO2 cells:> 60 µM, HUVECs:41.17 μM, 3T3-L1 cells:96.4 μM, U-373MG cells:68 μM, SK-MEL-28 cells:75 μM, Hep b3B cells:42.84 ± 2.01 µM, C2C12 cells:26.34 μg/mL, C-33-A cells:32.83 μM, HEK293T cells:3.42 μg/mL, SiHa cells:53.8 μM, HepG2 cells:27.71 μM, influenza virus:24.7 μM (EC50), A549 cells:> 20 μM, HeLa cells:58.1 μM |
| In vitro | METHODS: Normal human hepatocyte cell line LO2 and HCC cell line Hep3B were treated with Isoliquiritigenin (30-60 µM) for 24-72 h. Cell viability was measured by MTT assay. RESULTS: Isoliquiritigenin showed significant cytotoxicity against Hep3B cells with an IC50 of 42.84±2.01 µM at 48 h. This effect was concentration and time dependent. However, at the same Isoliquiritigenin stimulation intensity, the survival of LO2 cells was significantly less affected with an IC50 >60 µM.[1] METHODS: Human colorectal cancer cells HCT-116 were treated with Isoliquiritigenin (20 µM) for 24 h. Apoptosis was detected by Flow cytometry. RESULTS: Treatment of HCT-116 cells with Isoliquiritigenin resulted in a significant increase in apoptosis (17.26%) in the treated group compared to the NC group (7.37%). [2] |
| In vivo | METHODS: To assay anti-tumor activity in vivo, Isoliquiritigenin (50 mg/kg) was injected intraperitoneally into BALB/c-nu/nu mice bearing Hep3B xenografts once daily for three weeks. RESULTS: Isoliquiritigenin-treated mice had reduced tumor burden in terms of mean tumor size or xenograft weight. [1] |
| Synonyms | Isoliquiritigen, ISL, GU17 |
| Molecular Weight | 256.25 |
| Formula | C15H12O4 |
| Cas No. | 961-29-5 |
| Smiles | C(/C=C/C1=CC=C(O)C=C1)(=O)C2=C(O)C=C(O)C=C2 |
| Relative Density. | 1.384 g/cm3 |
| Storage | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 62.3 mg/mL (243.12 mM), Sonication is recommended. Ethanol: 22 mg/mL (85.85 mM), Sonication is recommended. H2O: < 1 mg/mL (insoluble or slightly soluble) | ||||||||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 5.1 mg/mL (19.9 mM), Suspension. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | ||||||||||||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||||||||||||
Ethanol/DMSO
DMSO
| |||||||||||||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.